MedPath

Sacral Neuromodulation & Urodynamics

Conditions
Overactive Bladder
Non-obstructive Urinary Retention
Interventions
Diagnostic Test: urodynamics
Registration Number
NCT03614767
Lead Sponsor
Universiteit Antwerpen
Brief Summary

In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).

Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Overactive bladder
  • Non-obstructive urinary retention
Exclusion Criteria
  • Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SuccessesurodynamicsPatients with \>50% improvement during test procedure of sacral neuromodulation.
FailuresurodynamicsPatients with \<50% improvement during test procedure of sacral neuromodulation.
Primary Outcome Measures
NameTimeMethod
Change in bladder sensation3 weeks

Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation

Change in bladder volume3 weeks

Change in bladder volume is measured before and after test procedure for sacral neuromodulation

Change in ice water test3 weeks

Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of antwerp

🇧🇪

Antwerpen, Edegem, Belgium

© Copyright 2025. All Rights Reserved by MedPath